A number of AR antagonists have been developed to treat advanced prostate cancer, such as Enzalutamide, Apalutamide, and Darolutamide.14 Unfortunately, patients with these AR antagonists ultimately developed drug resistance. Here, AR is linked to Familial prostate cancer.